Freeze-frames of enzymes in action have implications for a new cancer treatment concept

July 03, 2017

Cold Spring Harbor, NY - Over millions of years of evolution, cells have developed myriad ways of regulating the processes that enable them to thrive. Especially useful tools have been saved, or "conserved," over the eons, so that today we can find them in a broad spectrum of life forms, from the very primitive to the most complex.

Research published July 3, 2017 by structural biologists at Cold Spring Harbor Laboratory (CSHL) sheds light on how one such conserved mechanism works, with implications for the development of new cancer drugs.

Led by CSHL Professor and Howard Hughes Medical Institute Investigator Leemor Joshua-Tor, the team used x-ray crystallography to capture the equivalent of freeze-frames of a class of enzymes called TUTases. The pictures, at the resolution of individual atoms, shows them interacting with other molecules to regulate the activity of an important small RNA molecule called let-7.

Let-7, a microRNA, is a regulator of genes important in development. When expressed in humans, it's part of the process in which our stem cells differentiate into the various specialized cell types that populate our organs. In contexts in which it's important for stem cells to maintain their "stem-ness" - their ability to give rise indefinitely to more stem cells - let-7 needs to be deactivated.

Let-7 is of special interest because its deactivation in cancer cells is thought by some to confer upon those cells the stem cell-like property of being able to proliferate indefinitely. This has focused attention on understanding the mechanisms regulating whether let-7 is active or inactive.

The team's pictures show how TUT4 and TUT7 - two of the TUTase enzymes - act differently in the two contexts. In a differentiating cell, the TUTases correct a small genetically induced defect in the sequence of many let-7 precursors, enabling mature let-7 microRNAs to be generated. Those defects are ameliorated when a TUTase adds a single uridine ("u") molecule to the sequence of a let-7 precursor.

In a stem cell destined to retain its stem-ness, one of the TUTases adds not one but 30 uridines to the let-7 precursor, in this way marking it for destruction by another enzyme. "We have been able to capture the TUTases in these two different modes of action," says Joshua-Tor.

Joshua-Tor explains that TUTases are promising targets for new cancer therapies. In kidney and lung cancer cells, for example, in which let-7 levels are far below normal, TUTases involved in marking let-7 for destruction could perhaps be inhibited. Having extremely high resolution images of how they act in the molecular dance should help in that effort.
The team included first author Christopher Faehnl, a CSHL Research Investigator, and former Watson School of Biological Sciences student Jack Walleshauser. The work was supported by NIH grant R01-GM114147; the Cold Spring Harbor Laboratory Women in Science Award; and the Watson School of Biological Sciences.

"Multi-domain utilization by TUT4 and TUT7 in control of let-7 biogenesis" appears July 3, 2017 in Nature Structural and Molecular Biology. The authors are: Christopher R. Faehnle, Jack Walleshauser and Leemor Joshua-Tor. The paper can be accessed at:

About Cold Spring Harbor Laboratory

Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,100 people including 600 scientists, students and technicians. The Meetings & Courses Program annually hosts more than 12,000 scientists. The Laboratory's education arm also includes an academic publishing house, a graduate school and the DNA Learning Center with programs for middle and high school students and teachers. For more information, visit

Cold Spring Harbor Laboratory

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to